Function Testing 12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
,3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
a. Asthma
b. Sarcoidosis
c. Exertional ohypoxemia
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
d. Guillain-Barré osyndrome
ANS: oB
Sarcoidosis ois othe oonly osystemic odisease olisted othat oaffects ogas
oexchange. oDIF: o1 oREF: op. o9 o| op. o19 o| op. o21 o| op. o35 oOBJ: oEL-2
oMSC: oNBRC: oNone
5. Blood ogas oanalysis ois oused owith opatients owith oCOPD oto odo owhich
oof othe ofollowing?
a. Monitor oairway oresponsiveness.
b. Determine olevel oof ocardiopulmonary ofitness.
c. Detect opulmonary ohypertension.
d. Assess oneed ofor osupplementary oO2.
ANS: oD
Blood ogas oanalysis ois omost ocommonly oused oto odetermine othe oneed ofor osupplemental
ooxygen oand oto omanage opatients owho orequire oventilatory osupport.
DIF: 2 REF: p. o15 OBJ: EL-1
oMSC: oNBRC: oCPFT o2A-2
6. Which oof othe ofollowing ocause oemphysema?
1. 1- oAntitrypsin odeficiency
2. Exposure oto oenvironmental opollutants
3. Radiation otherapy
4. Cigarette osmoking
a. 1 o and o 2
b. 3 o and o 4
c. 1 o, o2, oand o 4
d. 2 o, o3, oand o 4
ANS: oC
Emphysema ois ocaused oprimarily oby ocigarette osmoking. oSome oemphysema ois ocaused oby
othe oabsence oof oa oprotective oenzyme. oChronic oexposure oto oenvironmental opollutants
ocan oalso ocontribute oto othe odevelopment oof oemphysema.
DIF: 1 REF: p. o11 OBJ: EL-3 o| oAL-2 MSC: oNBRC: oNone
7. An oadult opatient ocomplains oof ochest otightness oand ocough owhenever ohe ojogs oin ocold
oweather. oThese osymptoms oare oconsistent owith owhich oof othe ofollowing?
a. Cystic ofibrosis
b. Asthma
c. Pulmonary ohypertension
d. Idiopathic opulmonary ofibrosis
|